Updated on 16 October 2013
Major Indian companies already based at DuBiotech include a blend of biotechnology and pharmaceutical companies such as Sun Pharma, Epygen, Wockhardt, Lupin, and Life Cell and NeoBiocon, a joint venture company between UAE-based Neopharma and the Indian biotech innovator Biocon.
Mr Sanjay Verma said, "Economic and cultural links between the UAE with India date back more than a century and today trade between our two countries is worth in excess of $ 44 billion. I have seen a wealth of interest from Indian life science companies and potential investors in coming to Dubai to explore the possibilities. I look forward to assisting in their endeavors where I can."
In 2012, DuBiotech witnessed exceptional growth, issuing 40 commercial licenses in comparison to 21 in 2011. This reflects a year-on-year increase of 50 percent, now taking the total number of companies based in the free zone to 126. The business center is also now 100 percent occupied with a mix of both multinational and small and medium sized firms. DuBiotech offers organizations based in the free zone, services in regulatory affairs management, partnership development, registration and licensing, leasing and government services to help both start-ups and international firms set up and achieve their respective commercial targets.